In this blog, we discuss cognitive computing and other technologies with a focus on supply chain management and innovation. Other topics of discussion include digital enterprise transformation, marketing, the Internet of Things, and smart cities. Our goal is to advance the public discussion about how cognitive computing and other advanced technologies affect the world in which we live.
Bradd C. Hayes is the active editor of this blog.
“It’s taken a long time for the health care industry to embrace Big Data,” writes Jason Millman (@jasonmillman), “but those days are over. What that ultimately means for the industry — care
I recently listened to a provocative presentation given by Gary Atkinson (@GaryA_ARM), Director of Emerging Technologies at ARM, entitled “Can Technology Save Us From Ourselves?” The focus of his presentation was the
I’m pretty sure that when you read the word “patient” in the headline of this article, your first thought was about sick rather than healthy people. A patient in the healthcare sector,
We would all like to see healthcare costs reduced. As an employer, I know how important benefits are to my employees. Unfortunately, the cost of providing healthcare insurance continues to rise. Following
“Big data is transforming the way drugs are being developed and prescribed,” asserts Gail Dutton. “Among the innovations: drugs that already have been approved are reformulated or repurposed for other ailments.” [“How
“Big data has grown to prominence in the pharmaceutical market over recent years,” writes Lucy Hill, “turning into a key technology for businesses.” [“Big data becomes more prominent in pharma industry,” KL
Matthew Braga reports, “There exists an organization that, using nothing more than the cellphone in your pocket, can track where you are – and, with a certain degree of certainty, where you
Dr. Bonnie Feldman, Ellen M. Martin, and Tobi Skotnes report, “In healthcare, the data generated by mobile phones and sensors can give us new information about ourselves, extend the reach of our
Last fall an article in The Hindu reported, “Computer programs and algorithms developed in the last three decades are making realistic molecular simulations possible, which, in turn, are used to make drugs
Sharon Terry, President and Chief Executive Officer of Genetic Alliance, asserts, “I find myself becoming increasingly optimistic that we are approaching a tipping point for the consumer movement in health.” [“Big Data
All Rights Reserved. Privacy Policy | Terms and Conditions ©2024 Enterra Solutions LLC® | Click for Accessibility
inquiries@enterrasolutions.com
